Crossref
Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring
Iranian Journal of Blood and Cancer · 2022
DOI: 10.58209/ijbc.14.3.71 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Blood and Cancer, 2022. Verfasst von Maryam Panahi und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Panahi, M., Ghorbi, M. D., Amirpour, M., Nayebi, R., & Dehaghi, B. H. K. (2022). Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring. Iranian Journal of Blood and Cancer. https://doi.org/10.58209/ijbc.14.3.71
Vancouver
Panahi M, Ghorbi MD, Amirpour M, Nayebi R, Dehaghi BHK. Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring. Iranian Journal of Blood and Cancer. 2022. doi:10.58209/ijbc.14.3.71
BibTeX
@article{Panahi2022,
author = {Panahi, Maryam and Ghorbi, Mahmoud Dehghani and Amirpour, Mozhgan and Nayebi, Reika and Dehaghi, Bentol Hoda Kuhestani},
title = {Myelodysplastic Syndromes (MDS); diagnosis, classification, treatment and monitoring},
journal = {Iranian Journal of Blood and Cancer},
year = {2022},
doi = {10.58209/ijbc.14.3.71}
}
EUVIMED